Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Cellular Signalling
|
May 1, 1997
Oncoprotein signalling and mitosis
A D Laird, D Shalloway
Cancer Research
|
August 1, 1994
Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene
A D Laird, P I Brown, N Fausto
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 1, 1995
Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration
N Fausto, A D Laird, E M Webber
The Journal of Biological Chemistry
|
February 6, 1999
Characterization of Raf-1 activation in mitosis
A D Laird, D K Morrison, D Shalloway
The Journal of Biological Chemistry
|
November 10, 1995
Raf-1 is activated during mitosis
A D Laird, S J Taylor, M Oberst, et al.
Anti-Cancer Drug Design
|
July 11, 2000
Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent
D B Mendel, A D Laird, B D Smolich, et al.
Cancer Research
|
August 17, 2000
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors
A D Laird, P Vajkoczy, L K Shawver, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Cellular Signalling
|
May 1, 1997
Oncoprotein signalling and mitosis
A D Laird, D Shalloway
Cancer Research
|
August 1, 1994
Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene
A D Laird, P I Brown, N Fausto
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 1, 1995
Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration
N Fausto, A D Laird, E M Webber
The Journal of Biological Chemistry
|
February 6, 1999
Characterization of Raf-1 activation in mitosis
A D Laird, D K Morrison, D Shalloway
The Journal of Biological Chemistry
|
November 10, 1995
Raf-1 is activated during mitosis
A D Laird, S J Taylor, M Oberst, et al.
Anti-Cancer Drug Design
|
July 11, 2000
Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent
D B Mendel, A D Laird, B D Smolich, et al.
Cancer Research
|
August 17, 2000
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors
A D Laird, P Vajkoczy, L K Shawver, et al.
Page
of 1